Integra LifeSciences Holdings (IART)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 1,596,615 1,533,335 1,521,985 1,473,066 1,486,381 1,488,778 1,493,656 1,509,844 1,505,291 1,519,581 1,519,648 1,510,233 1,535,982 1,529,270 1,504,267 1,371,086 1,317,264 1,323,744 1,339,441 1,466,719
Total assets US$ in thousands 4,037,420 4,065,800 4,074,500 4,078,220 3,781,990 3,739,370 3,777,600 3,742,400 3,889,760 3,807,010 3,752,860 3,672,000 3,782,380 3,774,460 3,712,790 3,741,550 3,615,140 3,453,520 3,391,760 3,447,560
Total asset turnover 0.40 0.38 0.37 0.36 0.39 0.40 0.40 0.40 0.39 0.40 0.40 0.41 0.41 0.41 0.41 0.37 0.36 0.38 0.39 0.43

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,596,615K ÷ $4,037,420K
= 0.40

The total asset turnover of Integra LifeSciences Holdings has shown a fluctuating trend over the analyzed period. It decreased from 0.43 in March 2020 to 0.36 in December 2023, indicating that the company generated $0.36 in revenue for every dollar of assets during that time. There was a slight improvement in the total asset turnover in the following quarters, with values ranging between 0.36 and 0.41 up to December 2024. This suggests that Integra LifeSciences Holdings became more efficient in utilizing its assets to generate revenue towards the end of the analyzed period. Further monitoring of the total asset turnover will be necessary to assess the company's ongoing performance in this area.